In the last trading session, 51286.0 VolitionRX Ltd (AMEX:VNRX) shares changed hands as the company’s beta touched 1.20. With the company’s per share price at $0.65 changed hands at $0.04 or 5.69% during last session, the market valuation stood at $62.19M. VNRX’s last price was a discount, traded about -89.23% off its 52-week high of $1.23. The share price had its 52-week low at $0.43, which suggests the last value was 33.85% up since then. When we look at VolitionRX Ltd’s average trading volume, we note the 10-day average is 0.94 million shares, with the 3-month average coming to 274.53K.
VolitionRX Ltd (AMEX:VNRX) trade information
Instantly VNRX was in green as seen at the end of in last trading. With action 10.02%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -9.62%, with the 5-day performance at 10.02% in the green. However, in the 30-day time frame, VolitionRX Ltd (AMEX:VNRX) is -18.38% down. Looking at the short shares, we see there were 0.44 million shares sold at short interest cover period of 3.71 days.
VolitionRX Ltd (VNRX) estimates and forecasts
Data shows that the VolitionRX Ltd share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 6.23% over the past 6 months, a 44.00% in annual growth rate that is considerably higher than the industry average of 16.70%. Year-over-year growth is forecast to reach 101.20% up from the last financial year.
Consensus estimates given by 3 financial analysts project the company’s revenue in the current quarter to hit an average of 545.34k. 1 analysts are of the opinion that VolitionRX Ltd’s revenue for the current quarter will be 800k. The company’s revenue for the corresponding quarters a year ago was 243.97k and 171.54k respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 123.53%. The estimates for the next quarter sales put growth at 366.36%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 2.75%. The 2024 estimates are for VolitionRX Ltd earnings to increase by 39.00%.
VNRX Dividends
VolitionRX Ltd is expected to release its next quarterly earnings report in January.
VolitionRX Ltd (AMEX:VNRX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 22.82% of VolitionRX Ltd shares while 19.11% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 24.76%. There are 19.11% institutions holding the VolitionRX Ltd stock share, with LAGODA INVESTMENT MANAGEMENT, L.P. the top institutional holder. As of 2024-06-30, the company held 6.6352% of the shares, roughly 5.44 million VNRX shares worth $3.29 million.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 0.7768% or 0.64 million shares worth $0.39 million as of 2024-06-30.
